Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters: A randomized, placebo-controlled trial

PLoS ONE

Volumn 5, Issue 5, 2010, Pages

  Slobbe, Lennert ^a   Doorduijn, Jeanette K ^a   Lugtenburg, Pieternella J ^a   Barzouhi, Abdelilah El ^a   Boersma, Eric ^a   van Leeuwen, Willem B ^a   Rijnders, Bart J A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ADULT; AGED; ARTICLE; BACTEREMIA; CATHETER CARE; CATHETER INFECTION; CATHETER THROMBOSIS; CENTRAL VENOUS CATHETER; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DROWSINESS; FEMALE; HOT FLUSH; HUMAN; INDWELLING CATHETER; INFECTION PREVENTION; INTERMETHOD COMPARISON; LAVAGE; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; RANDOMIZED CONTROLLED TRIAL; SYNCOPE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; CATHETER-RELATED INFECTIONS; CATHETERS, INDWELLING; DRUG ADMINISTRATION SCHEDULE; ETHANOL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PLACEBOS; YOUNG ADULT;

BACTERIA (MICROORGANISMS);

EID: 77956296627     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010840     Document Type: Article

References (39)

1. Digiovine B, Chenoweth C, Watts C, Higgins M (1999) The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 160: 976-981.
2. Pittet D, Tarara D, Wenzel RP (1994) Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. Jama 271: 1598-1601.
3. Rello J, Ochagavia A, Sabanes E, Roque M, Mariscal D, et al. (2000) Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 162: 1027-1030.
4. Wenzel RP, Edmond MB (2001) The impact of hospital-acquired bloodstream infections. Emerg Infect Dis 7: 174-177.
5. Byers K, Adal K, Anglim A (1995) Case fatality rate for catheter-related bloodstream infections (CRBSI): a meta-analysis [Abstract]. In: Proceedings of the 5th Annual Meeting of the Society for Hospital Epidemiology of America San Diego, USA.
6. Maki DG, Mermel LA (1998) Infections due to infusion therapy. In: Bennet JV, Brachman PS, eds. Hospital Infections, 4th ed. Philadelphia: Lippincott-Raven. pp 689-724.
7. Raad I, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, et al. (1993) Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis 168: 400-407.
8. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, et al. (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 49: 1-45.
9. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, et al. (2002) Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 30: 476-489.
10. Carratala J, Niubo J, Fernandez-Sevilla A, Juve E, Castellsague X, et al. (1999) Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer. Antimicrob Agents Chemother 43: 2200-2204.
11. Henrickson KJ, Axtell RA, Hoover SM, Kuhn SM, Pritchett J, et al. (2000) Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: A randomized, multicenter, double-blind trial. J Clin Oncol 18: 1269-1278.
12. Safdar N, Maki DG (2006) Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: a meta-analysis of prospective, randomized trials. Clin Infect Dis 43: 474-484.
13. Raad I, Hanna H, Maki D (2007) Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis 7: 645-657.
14. Sampath LA, Tambe SM, Modak SM (2001) In vitro and in vivo efficacy of catheters impregnated with antiseptics or antibiotics: evaluation of the risk of bacterial resistance to the antimicrobials in the catheters. Infect Control Hosp Epidemiol 22: 640-646.
15. Dannenberg C, Bierbach U, Rothe A, Beer J, Korholz D (2003) Ethanol-lock technique in the treatment of bloodstream infections in pediatric oncology patients with broviac catheter. J Pediatr Hematol Oncol 25: 616-621.
16. Onland W, Shin CE, Fustar S, Rushing T, Wong WY (2006) Ethanol-lock technique for persistent bacteremia of long-term intravascular devices in pediatric patients. Arch Pediatr Adolesc Med 160: 1049-1053.
17. Broom J, Woods M, Allworth A, McCarthy J, Faoagali J, et al. (2008) Ethanol lock therapy to treat tunnelled central venous catheter-associated blood stream infections: results from a prospective trial. Scand J Infect Dis 40: 399-406.
18. Metcalf SC, Chambers ST, Pithie AD (2004) Use of ethanol locks to prevent recurrent central line sepsis. J Infect 49: 20-22.
19. Mouw E, Chessman K, Lesher A, Tagge E (2008) Use of an ethanol lock to prevent catheter-related infections in children with short bowel syndrome. J Pediatr Surg 43: 1025-1029.
20. Opilla MT, Kirby DF, Edmond MB (2007) Use of ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients. JPEN J Parenter Enteral Nutr 31: 302-305.
21. Sanders J, Pithie A, Ganly P, Surgenor L, Wilson R, et al. (2008) A prospective double-blind randomized trial comparing intraluminal ethanol with heparinized saline for the prevention of catheter-associated bloodstream infection in immunosuppressed haematology patients. J Antimicrob Chemother 62: 809-815.
22. Blot F, Nitenberg G, Chachaty E, Raynard B, Germann N, et al. (1999) Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet 354: 1071-1077.
23. Safdar N, Fine JP, Maki DG (2005) Meta-analysis: methods for diagnosing intravascular device-related bloodstream infection. Ann Intern Med 142: 451-466.
24. Maki DG, Weise CE, Sarafin HW (1977) A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 296: 1305-1309.
25. van Belkum A, Kluytmans J, van Leeuwen W, Bax R, Quint W, et al. (1995) Multicenter evaluation of arbitrarily primed PCR for typing of Staphylococcus aureus strains. J Clin Microbiol 33: 1537-1547.
26. Welsh J, McClelland M (1990) Fingerprinting genomes using PCR with arbitrary primers. Nucleic Acids Res 18: 7213-7218.
27. Nouwen JL, Wielenga JJ, van Overhagen H, Lameris JS, Kluytmans JA, et al. (1999) Hickman catheter-related infections in neutropenic patients: insertion in the operating theater versus insertion in the radiology suite. J Clin Oncol 17: 1304.
28. Maki DG, Kluger DM, Crnich CJ (2006) The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 81: 1159-1171.
29. Crnich CJ, Duster M, Jones A, Maki DG (2009) Prospective Randomized Double-Blind Trial of an Ethanol Lock for Prevention of CLABSI [Abstract]. In: 49th Interscience Conference on Antimicrobial Agents and Chemotherapy San Francisco, USA.
30. Ingram LO, Buttke TM (1984) Effects of alcohols on micro-organisms. Adv Microb Physiol 25: 253-300.
31. Percival SL, Kite P (2007) Intravascular catheters and biofilm control. J Vasc Access 8: 69-80.
32. Laird J, Soutar R, Butcher I (2005) Complications of the ethanol-lock technique in the treatment of central venous catheter sepsis. J Infect 51: 338.
33. McHugh GJ, Wild DJ, Havill JH (1997) Polyurethane central venous catheters, hydrochloric acid and 70% ethanol: a safety evaluation. Anaesth Intensive Care 25: 350-353.
34. Crnich CJ, Halfmann JA, Crone WC, Maki DG (2005) The effects of prolonged ethanol exposure on the mechanical properties of polyurethane and silicone catheters used for intravascular access. Infect Control Hosp Epidemiol 26: 708-714.
35. Maiefski M, Rupp ME, Hermsen ED (2009) Ethanol lock technique: review of the literature. Infect Control Hosp Epidemiol 30: 1096-1108.
36. Balestrino D, Souweine B, Charbonnel N, Lautrette A, Aumeran C, et al. (2009) Eradication of microorganisms embedded in biofilm by an ethanol-based catheter lock solution. Nephrol Dial Transplant 24: 3204-3209.
37. Qu Y, Istivan TS, Daley AJ, Rouch DA, Deighton MA (2009) Comparison of various antimicrobial agents as catheter lock solutions: preference for ethanol in eradication of coagulase-negative staphylococcal biofilms. J Med Microbiol 58: 442-450.
38. Costa SF, Barone AA, Miceli MH, van der Heijden IM, Soares RE, et al. (2006) Colonization and molecular epidemiology of coagulase-negative Staphylococcal bacteremia in cancer patients: a pilot study. Am J Infect Control 34: 36-40.
39. Costa SF, Miceli MH, Anaissie EJ (2004) Mucosa or skin as source of coagulase-negative staphylococcal bacteraemia? Lancet Infect Dis 4: 278-286.